✦ LIBER ✦
Efficacy and safety of short-term adalimumab treatment in patients with active Crohn's disease who lost response or showed intolerance to infliximab: a prospective, open-label, multicentre trial
✍ Scribed by J. HINOJOSA; F. GOMOLLÓN; S. GARCÍA; G. BASTIDA; J. L. CABRIADA; C. SARO; D. CEBALLOS; M. PEÑATE; M. A. GASSULL; ON BEHALF OF GETECCU GRUPO ESPAÑOL DE TRABAJO PARA EL ESTUDIO DE E. CROHN Y COLITIS ULCEROSA (SPANISH SCIENTIFIC GROUP ON CROHN'S DISEASE AND ULCERATIVE COLITIS)
- Book ID
- 108604863
- Publisher
- John Wiley and Sons
- Year
- 2007
- Tongue
- English
- Weight
- 557 KB
- Volume
- 25
- Category
- Article
- ISSN
- 0269-2813
No coin nor oath required. For personal study only.